SE7803549L - 5-(2-pyrroyl)-1,2-dihydro-3h-pyrrolo (1,2-a)-pyrrol-1-karbonsyraderivat och sett att framstella desamma - Google Patents

5-(2-pyrroyl)-1,2-dihydro-3h-pyrrolo (1,2-a)-pyrrol-1-karbonsyraderivat och sett att framstella desamma

Info

Publication number
SE7803549L
SE7803549L SE7803549A SE7803549A SE7803549L SE 7803549 L SE7803549 L SE 7803549L SE 7803549 A SE7803549 A SE 7803549A SE 7803549 A SE7803549 A SE 7803549A SE 7803549 L SE7803549 L SE 7803549L
Authority
SE
Sweden
Prior art keywords
pyrroyl
pyrrol
pyrrolo
dihydro
preparing
Prior art date
Application number
SE7803549A
Other languages
English (en)
Other versions
SE436648B (sv
Inventor
J M Muchowski
A F Kluge
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of SE7803549L publication Critical patent/SE7803549L/sv
Publication of SE436648B publication Critical patent/SE436648B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SE7803549A 1977-03-31 1978-03-29 Analogiforfarande for framstellning av 5-(2-pyrroyl)-1,2-dihydro-3h-pyrrolo/1,2-a/pyrrol-1-karbonsyraderivat SE436648B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/783,090 US4097579A (en) 1977-03-31 1977-03-31 5-(2-Pyrroyl)-1,2-dihydro-3H-pyrrolo 1,2-a!pyrrole-1-carboxylic acid derivatives and process for the production thereof

Publications (2)

Publication Number Publication Date
SE7803549L true SE7803549L (sv) 1978-10-01
SE436648B SE436648B (sv) 1985-01-14

Family

ID=25128138

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7803549A SE436648B (sv) 1977-03-31 1978-03-29 Analogiforfarande for framstellning av 5-(2-pyrroyl)-1,2-dihydro-3h-pyrrolo/1,2-a/pyrrol-1-karbonsyraderivat

Country Status (14)

Country Link
US (1) US4097579A (sv)
JP (1) JPS53121792A (sv)
AU (1) AU518169B2 (sv)
BE (1) BE865247A (sv)
CA (1) CA1113938A (sv)
DE (1) DE2813373A1 (sv)
ES (2) ES468267A1 (sv)
FR (1) FR2385719A1 (sv)
GB (1) GB1581411A (sv)
IE (1) IE46506B1 (sv)
IT (1) IT1107833B (sv)
NL (1) NL7803378A (sv)
NZ (1) NZ186797A (sv)
SE (1) SE436648B (sv)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4140698A (en) * 1977-07-25 1979-02-20 Syntex (Usa) Inc. 1,2-Dihydro-3H-pyrrolo[1,2-a]pyrrole-1-nitriles
US4232038A (en) * 1979-08-31 1980-11-04 Syntex (U.S.A.) Inc. 5-Alkylsulfinylbenzoyl- and 5-alkylsulfonylbenzoyl-1,2-dihydro-3H-pyrrolo[1,]pyrrole-1-carboxylic acids
US4344943A (en) * 1980-06-09 1982-08-17 Syntex (U.S.A.) Inc. 6-Chloro- or 6-bromo-1,2-dihydro-3H-pyrrolo[1,2-a]-pyrrole-1-carboxylic acids and derivatives thereof
US4456759A (en) * 1980-10-20 1984-06-26 Syntex (U.S.A.) Inc. 5-Benzoyl-7-halo-1,2-dihydro-3H-pyrrolo-[1,2-a]pyrrole-1,1-dicarboxylic acids and esters thereof
US4353829A (en) * 1980-11-21 1982-10-12 Syntex (U.S.A.) Inc. Process for 5-aroylation of 1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic esters
US4434175A (en) 1981-08-10 1984-02-28 Merck & Co., Inc. Nonsteroidal compounds as anti-inflammatory and analgesic agents
WO1983001382A1 (en) * 1981-10-13 1983-04-28 Mroszczak, Edward Gastrointestinal sparing thioester pro-drugs
DE3368416D1 (en) * 1982-02-25 1987-01-29 Beecham Group Plc Aroyl pyrrolizine compounds, process for their preparation and pharmaceutical compositions containing them
US4457941A (en) * 1982-03-22 1984-07-03 Syntex (U.S.A.) Inc. Use of pyrrolo-pyrrole in treating microvascular diseases associated with diabetes
US4454151A (en) * 1982-03-22 1984-06-12 Syntex (U.S.A.) Inc. Use of pyrrolo pyrroles in treatment of ophthalmic diseases
US4612325A (en) * 1982-06-08 1986-09-16 Syntex (U.S.A) Inc. 5-Aroyl-6-alkylthio-1,2-dihydro-3H-pyrrolo(1,2-A)pyrrole-1-carboxylic acids and use thereof as analgesics and anti-inflammatories
US4511724A (en) * 1982-06-10 1985-04-16 Merck & Co., Inc. 5-(Pyrrol-2-oyl)-1,2-dihydro-3H-pyrrolo [1,2-a]pyrrole derivatives as anti-inflammatory and analgesic agents
JPS5910589A (ja) * 1982-06-10 1984-01-20 メルク　エンド　カムパニー　インコーポレーテツド 抗炎症剤および鎮痛剤として新規な５−（ピロ−ル−２−オイル）−１，２−ジヒドロ−３Ｈ−ピロロ〔１，２−ａ〕ピロ−ル誘導体
US4533671A (en) * 1982-10-08 1985-08-06 Merck & Co., Inc. 5-(2,3-Dihydro-1H-pyrrolizin-5-oyl)-2-alkanoic or carboxylic acids and analogs as anti-inflammatory and analgesic agents
US4536512A (en) * 1982-10-08 1985-08-20 Merck & Co., Inc. 5-(2,3-Dihydro-1H-pyrrolizin-5-oyl)-2,3-dihydro-1H-pyrrolizine-1-alkanoic or carboxylic acids and use thereof as anti-inflammatory and analgesic agents
EP0117675B1 (en) * 1983-02-19 1986-07-23 Beecham Group Plc Benzofuran and benzothiophene-carboxylic-acid derivatives
US4622407A (en) * 1984-04-26 1986-11-11 Merck & Co., Inc. Resolution of racemic derivatives of 5-(1-methyl-5-methylthiopyrrol-2-oyl)-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-2-carboxylic acid and analogs
US4988822A (en) * 1986-05-29 1991-01-29 Syntex (U.S.A.) Inc. Intermediates for preparing 5-aroyl-1,2-dihydro-3H-pyrrolo(1,2-A)pyrrole-1,1-dicarboxylates
US4873340A (en) * 1986-05-29 1989-10-10 Syntex (U.S.A.) Inc. Process for preparing 5-aroyl-1,2-dihydro-3H-pyrrolo[1,2-A]pyrrole-1,1-dicarboxylates
US4874872A (en) * 1987-01-14 1989-10-17 Syntex (U.S.A.) Inc. Process for preparing (+)-2,3-dihydro-1H-pyrrolo[1,2-A]pyrrole-1,7-dicarboxylates
HU198927B (en) * 1987-01-14 1989-12-28 Richter Gedeon Vegyeszet Process for producing 1-/substituted aminomethyl/-octa-hydroindolo-(2,3-a)quinolizine derivatives, pharmaceutically applicable acid addition salts thereof, as well as pharmaceutical compositions comprising same
US4835288A (en) * 1987-01-14 1989-05-30 Syntex Inc. Process for preparing (+)-2,3-dihydro-1H-pyrrolo[1,2-a]pyrrole-1,7-dicarboxylates
US4849526A (en) * 1987-01-14 1989-07-18 Syntex (U.S.A.) Inc. Process for preparing (±)-2,3-dihydro-1H-pyrrolo[1,2-A]pyrrole-1,7-dicarboxylates
US4874871A (en) * 1987-03-25 1989-10-17 Syntex (U.S.A.) Inc. Process for preparing (+)-2,3-Dihydro-1H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid and related compounds
US5110493A (en) * 1987-09-11 1992-05-05 Syntex (U.S.A.) Inc. Ophthalmic NSAID formulations containing a quaternary ammonium preservative and a nonionic surfactant
US5414011A (en) * 1987-09-11 1995-05-09 Syntex (U.S.A.) Inc. Preservative system for ophthalmic formulations
AU7255394A (en) * 1993-07-08 1995-02-06 Cygnus Therapeutic Systems Monolithic matrix transdermal delivery system
US5621115A (en) * 1996-02-21 1997-04-15 Ohmeda Pharmaceutical Products Division Inc. Methods for preparing 5-aroyl-1,2-dihydro-3H-pyrrolo-[1,2-A]pyrrole-1-carboxylic acids
US6191285B1 (en) 1997-07-03 2001-02-20 Abbott Laboratories Process for the preparation of ketorolac tromethamine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL293572A (sv) * 1962-06-07
US3846447A (en) * 1972-08-03 1974-11-05 Mcneilab Inc Preparation of 5-aroyl-pyrroles and intermediates therefor
JPS539789A (en) * 1976-07-14 1978-01-28 Syntex Inc Production of 55*22floyl** * 55*22thenoyl** * 55*33 floyl** and 55*33thenoyl** 1*22dihydroo3hhpyroro * 1*22a*pyrolee11carboxylic acid derivative

Also Published As

Publication number Publication date
FR2385719B1 (sv) 1980-07-18
IT7867706A0 (it) 1978-03-30
IE46506B1 (en) 1983-06-29
JPS53121792A (en) 1978-10-24
NZ186797A (en) 1979-12-11
CA1113938A (en) 1981-12-08
DE2813373A1 (de) 1978-10-05
FR2385719A1 (fr) 1978-10-27
ES468267A1 (es) 1979-10-01
SE436648B (sv) 1985-01-14
IE780605L (en) 1978-09-30
AU518169B2 (en) 1981-09-17
ES476535A1 (es) 1979-12-01
IT1107833B (it) 1985-12-02
AU3461178A (en) 1979-10-04
US4097579A (en) 1978-06-27
JPS647997B2 (sv) 1989-02-10
DE2813373C2 (sv) 1989-11-09
GB1581411A (en) 1980-12-10
NL7803378A (nl) 1978-10-03
BE865247A (fr) 1978-09-25

Similar Documents

Publication Publication Date Title
SE7803549L (sv) 5-(2-pyrroyl)-1,2-dihydro-3h-pyrrolo (1,2-a)-pyrrol-1-karbonsyraderivat och sett att framstella desamma
NO147670C (no) Analogifremgangsmaate for fremstilling av antivirale amin-derivater.
SE427274B (sv) Forfarande for framstellning av derivat av 1,2-ditiol-3-tion med verkan mot blodparasiter
FI782527A (fi) Pyrido(1,2-a)pyrimidin-derivat foerfarande foer deras framstaellning och desamma innehaollande farmaceutiska blandningar
NO151895C (no) Fremgangsmaate for fremstilling av pyrido-indolderivater
SE427273B (sv) Forfarande for framstellning av derivat av 1,2-ditiol-3-tion med verkan mot blodparasiter
SE434643B (sv) Analogiforfarande for framstellning av 5-aroyl-1,2-dihydro-3h-pyrrolo(1,2-a)-pyrrol-1-karbonsyraderivat
NO151365C (no) Fremgangsmaate for fremstilling av 4-halogen-dihydropyran-derivater.
NO156086C (no) Analogifremgangsmaate for fremstilling av substituerte heterocykliske fenoksyaminer.
AR229519A1 (es) Procedimiento de preparacion de derivados de 2,3-dihidro-9-fenil-1h-pirazolo(1,2-a)-indazolio
NO152645C (no) Fremgangsmaate for fremstilling av klordioksyd.
NO157143C (no) Fremgangsmaate for fremstilling av karbapen-2-em-derivater.
SE7804878L (sv) Forfarande for framstellning av 1,2-dikloretan
FI782517A (fi) Foerfarande foer framstaellning av 2,3-polymetylen-4-oxo-4h-pyrido(1,2-a)-pyrimidiner
SE434401B (sv) Forfarande for framstellning av 2-karbobensoxiamino-oktahydro-oxazolo(3,2-a)pyrrolo(2,1-c)pyrazinderivat
AR219924A1 (es) Procedimiento de preparacion de nuevos derivados de 7-cloro-3-alcoxi (c1-c4) carbonil-5-(2-halofenil) -2-oxo-2,3-dihidro- (1h) -1,4 benzodiacepinas
ES491153A0 (es) Procedimiento de preparar derivados pirrolo(1,2-a)pirimidi- nicos
ES495745A0 (es) Procedimiento de preparacion de derivados de la piridina.
SE7809831L (sv) Forfarande for framstellning av barrvedsmassa
NO792659L (no) Fremgangsmaate for fremstilling av karbostyrilderivater
NO784392L (no) Fremgangsmaate ved fremstilling av antiallergiske pyrido (1,2-a)-pyrimidin-derivater
SE7709402L (sv) Forfarande for framstellning av tetrahydropyridinderivat
NO801724L (no) Fremgangsmaate for fremstilling av ergopeptin-derivater
MX5725E (es) Procedimiento para la preparacion de derivados de 5,8-dihidrofuro-(3,2-b)-1,8-naftiridina
NO800564L (no) Fremgangsmaate for fremstilling av penicillinderivater

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7803549-0

Effective date: 19911009

Format of ref document f/p: F